About HTL

HTL is a leading biotech and industrial player in the development and production of innovative, pharmaceutical-grade biopolymers that are used by leading pharmaceutical and medical device companies to transform the lives of millions of patients in multiple therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology, and urology.

A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined its innovative functional biopolymer platform that has enabled it to produce "customised", pharmaceutical grade products for customers worldwide for over 25 years.

HTL is at the forefront of innovation in the biopolymer industry to meet tomorrow's medical needs by creating new types of biopolymers and chemical modifications, while exploring the untapped potential of biopolymers in innovative applications such as bioprinting or drug delivery.‍

HTL conducts its production activities in fully compliant cGMP facilities.

To find out more about HTL:

  • FR
  • 2015
    On CPHI since
  • 3
  • 100 - 249
Company types
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Frankfurt, Germany
1-3 November 2022

Products from HTL (4)

  • Hyaluronan / hyaluronic acid by HTL

    Product Hyaluronan / hyaluronic acid by HTL

    Hyaluronic acid, also known as Hyaluronan, is a biopolymer that is naturally present in the human body. It has been used for many years as a raw material or ingredient for medical products in various fields including ophthalmology, orthopaedics and dermatology.
    HTL produces injectable grade Hyaluro...
  • Chondroitin by fermentation by HTL

    Product Chondroitin by fermentation by HTL

    While most Chondroitin sulfate on the market is of animal origin, HTL is developing a new source of Chondroitin of non-animal origin with the use of fermentation. Chondroitin sulfate can then be obtained by sulfation. 

    Characteristics and benefits of Chondroitin by fermentation:  ...
  • Heparosan by HTL

    Product Heparosan by HTL

    HTL is developing Heparosan, a promising raw material for the design of innovative medical devices. Under license, HTL will be the sole producer of medical grade, high molecular weight Heparosan by fermentation (20 kDa to 2MDa). Safe for use in humans, Heparosan is an endogenous GlycosAminoGlycan with...
  • Functionalized GlycosAminoGlycan Derivatives

    Product Functionalized GlycosAminoGlycan Derivatives

    HTL offers the tailor-made development of functionalized derivatives of Glycosaminoglycans, such as modified Hyaluronic Acid, Heparosan and Chondroitin. Developing new functionalities by chemical modification allows the optimization of existing uses of these biopolymers, but also opens opportunities for n...

HTL Resources (3)

  • News HTL launches a new, cutting-edge bioproduction unit for pharmaceutical-grade biopolymers

    HTL is a French biotechnology company and industrial player that has become a world leader in the development and production of pharmaceutical-grade biopolymers. Thanks to this new investment of 50 million euros, HTL will more than double its production capacity, allowing it to accelerate its international development and become the world's largest producer of pharmaceutical-grade hyaluronic acid. Biopolymers produced by this unit will enable an increasing number of leading companies in the pharmaceutical and medical devices sectors to offer innovative therapeutic solutions to their patients worldwide.
  • Brochure HTL corporate brochure


    Beyond, together.
  • Video HTL video - Beyond, Together.

    All over the world, men and women are living longer. They aspire to better health, greater well-being, and living life to its fullest, whatever their age. Since its creation, HTL’s mission has been to invent innovative solutions to meet the health challenges of the future. And because the best remedies are those that reside in us, we have focused our research on the biopolymers naturally existing in the human body...